相关实验视频
Updated: May 7, 2025

08:45
Polygraphic Recording Procedure for Measuring Sleep in Mice
Published on: January 25, 2016
23.3K
阿莫达菲尼尔作为单疗法用于治疗随着 kataplexy 的麻醉症
Arshia Ahmed1, Sara Tariq1, Salman J Khan2,1
1Internal Medicine, Guthrie Lourdes Hospital, Binghamton, USA.
Cureus
|December 31, 2024
概括
兴奋剂阿莫达菲尼尔在麻醉症病例中有效治疗过度白天嗜睡和触发症. 这一发现为带有触角症的麻醉症提供了新的治疗选择.
科学领域:
- 神经学 神经学
- 药理学 药理学是指药理学的学科.
背景情况:
- 随着 kataplexy 的麻醉症通常是用氧酸盐或 pitolisant 管理.
- 阿尔莫达菲尼尔是一种促进清醒的药物,是FDA批准的过度白天嗜睡 (EDS) 在麻醉症,但不是专门用于触发症.
研究的目的:
- 报告一种带有 kataplexy 的麻醉症病例,其中armodafinil单一治疗改善了EDS和 kataplexy.
- 探索阿莫达菲尼尔作为治疗触角症的潜力.
主要方法:
- 一份临床病例报告,详细介绍了治疗麻醉症患者的治疗方法.
- 观察阿莫达菲尼尔单独治疗的症状改善.
主要成果:
- 阿莫达菲尼尔单一治疗成功改善了过度白天嗜睡 (EDS).
- 阿莫达菲尼尔单一治疗也证明了在减少触角症症状方面的有效性.
- 患者在阿莫达菲尼尔治疗时保持清醒.
结论:
- 阿莫达菲尼尔单一治疗可以有效治疗EDS和麻醉症的触角症.
- 这一案例表明,阿莫达菲尼尔可能是一个可行的替代方案来管理触角症,超出其已批准的EDS的适应症.
- 需要进一步的研究来证实阿莫达菲尼尔在治疗 kataplexy 的有效性.
更多相关视频
相关概念视频
Narcolepsy
82
Narcolepsy is a chronic sleep disorder characterized by pervasive, uncontrolled sleepiness and other sleep disturbances. One of its hallmark symptoms is an abrupt transition to REM sleep upon falling asleep, which causes symptoms typically associated with this phase to occur unexpectedly during wakefulness. These include the following symptoms, which typically last from a minute or two to half an hour.
82
Management of Insomnia
181
The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
181
Parkinson's Disease: Treatment
148
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
148
Sedatives and Hypnotics Drugs: Miscellaneous Agents
96
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
96
Sleep-Wake Cycles
1.1K
Sleep is an essential physiological process vital to maintaining overall well-being. The reticular activating system (RAS), a network of neurons in the brainstem, regulates wakefulness and sleep. While it may seem passive, sleep consists of distinct cycles, each with its unique characteristics and functions. Two key sleep phases are non-rapid eye movement (NREM) and rapid eye movement (REM).
NREM Sleep
NREM sleep comprises four progressive stages that seamlessly merge:
NREM Sleep
NREM sleep comprises four progressive stages that seamlessly merge:
1.1K
Antidepressant Drugs: MAOIs and Other Agents
157
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
157

